• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Trials for Novel Influenza Vaccine Likely by Spring

tetano

Editor, Senior Moderator
January 5, 2012 — A precautionary vaccine against the novel swine influenza virus, which has sickened 12 people in 5 states since July, is in development and will likely be ready for clinical trials this spring, a spokesperson for the Department of Health and Human Services (HHS) told Medscape Medical News.

..

subscription required

http://www.medscape.com/viewarticle/756438
 
Re: Trials for Novel Influenza Vaccine Likely by Spring

I have sent an email asking Gretchen Michaels to confirm her comments. The full article is here:

http://www.medscape.com/viewarticle/756438

"HHS routinely develops vaccines to test against novel influenza viruses "with potential pandemic potential," said Gretchen Michael, director of communications for the department's Office of the Assistant Secretary for Preparedness and Response. Examples of other novel viruses that have triggered precautionary vaccine development, said Ms. Michael, include avian influenza viruses such as A(H9N2) and A(H7N5).
 
Re: Trials for Novel Influenza Vaccine Likely by Spring

She indicated to me that the bits in quotes on that article are not entirely accurate.

To clarify she said that the HHS routinely has clinical investigational lots of vaccine prepared by manufacturers for clinical testing against novel influenza viruses with possible pandemic potential (e.g., H5N1, H9N2, H7N5, etc.).

So as part of this process they asked manufacturers to also prepare clinical investigational lots of swine origin H3N2 vaccine for clinical testing by the NIH and the manufacturers.
 
Back
Top